Donate
/
Initiative
/
Securing medication pumps (Desferal for iron chelation) for thalassemia patients
Created Date
08 January 2024
Modified Date
12 June 2024
Omani Society for Hereditary Blood Diseases
Securing medication pumps (Desferal for iron chelation) for thalassemia patients
Thalassemia patients suffer from increased iron levels in the blood due to regular blood transfusions (every 3 weeks or as per the patient's needs). Accumulation of iron in the body leads to severe complications if not reduced through iron-chelating medications like Desferal, administered through drug pumps. Contribute with us to alleviate their suffering